Abbott Laboratories is making hearts flutter—literally and financially—with its successful TRILUMINATE™ trial for the ...
Abbott closed up 1.4% at $132.65, outperforming the S&P 500's modest 0.55% rise and making investors do a double take.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback